Publications

the anti-saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of crohn's disease and predicting inflammatory disease.

to determine the utility of the anti-saccharomyces cerevisiae antibody (asca) elisa test developed in manitoba in 2001 in a population-wide sample referred from physicians across manitoba in their investigation of patients with gastrointestinal symptoms.